You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 49 No. 4, April 1992 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Event-Related Potentials in Human Immunodeficiency Virus Infection

A Prospective Study

John A. Messenheimer, MD; Kevin R. Robertson, PhD; Jean W. Wilkins, PhD; Josey C. Kalkowski, R EEG/EPT; Colin D. Hall, MBChB

Arch Neurol. 1992;49(4):396-400.


Abstract



• P3 event-related evoked potentials (ERP) were recorded from 47 human immunodeficiency virus (HIV)—positive subjects examined twice and 29 HIV-positive subjects examined three times at 6-month intervals. The P3 latency significantly increased over time for asymptomatic subjects and subjects with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. N2 latency was prolonged relative to control values in both HIV-positive groups but did not increase with time. The P3 latency correlated with neuropsychologic measures of motor control and speed of mental processing. Confounding factors (active or previous substance abuse, developmental disabilities, and history of closed head injury or epilepsy) did not significantly affect ERP latencies. Endogenous ERP components are frequently abnormal in HIV-positive subjects and the P3 latency progressively increases over time. Continued follow-up is required to determine the clinical utility of ERP studies in the HIV-positive population.



Author Affiliations



From the Department of Neurology, AIDS Neurologic Center, University of North Carolina, Chapel Hill.


Footnotes



Accepted for publication November 12, 1991.

Reprint requests to Department of Neurology, 7025 Burnett Womack Bldg, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599 (Dr Messenheimer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Substance Use Disorder Exacerbates Brain Electrophysiological Abnormalities in a Psychiatrically-III Population
Braverman and Blum
Clin EEG Neurosci 1996;27:5-28.
ABSTRACT | FULL TEXT  

Event-Related Potentials in HIV Infection: Evidence for Impact of Antiretroviral Treatment
Evers et al.
Arch Neurol 1996;53:715-716.
ABSTRACT  

Delayed Latency of the Event-Related Brain Potential P3A Component in HIV Disease: Progressive Effects With Increasing Cognitive Impairment
Fein et al.
Arch Neurol 1995;52:1109-1118.
ABSTRACT  

Serial Brainstem Auditory Evoked Responses in Infants and Children with AIDS
Frank and Pahwa
Clin EEG Neurosci 1993;24:160-165.
FULL TEXT  

Vitamin B12 Deficiency and Nervous System Disease in HIV Infection
Robertson et al.
Arch Neurol 1993;50:807-811.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.